Asherson, P. (2004) Attention-deficit hyperactivity disorder in the post-genomic era. European Child and Adolescent Psychiatry, 13 (suppl. 1), 150–170.
Asherson, P. (2005) Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Review of Neurotherapeutics, 5, 525–539.
Banaschewski, T., Coghill, D., Santosh, P., et al (2006) Long-acting medications for the hyperkinetic disorders: a systematic review and European treatment guideline.
European Child and Adolescent Psychiatry, in press.
Faraone, S. V., Biederman, J., Spencer, T., et al (2000) Attention-deficit/hyperactivity disorder in adults: an overview. Biological Psychiatry, 48, 9–20.
Faraone, S. V., Spencer, T., Aleardi, M., et al (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology
Faraone, S. V., Biederman, J. & Mick, E. (2006) The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine, 36, 159–165.
Simpson, D. & Plosker, G. L. (2004) Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. Drugs, 64, 205–222.
Taylor, E., Dopfner, M., Sergeant, J., et al (2004) European clinical guidelines for hyperkinetic disorder – first upgrade. European Child and Adolescent Psychiatry, 13 (suppl. 1), 17–130.
Weiss, M. & Murray, C. (2003) Assessment and management of attention-deficit hyperactivity disorder in adults. Canadian Medical Association Journal, 168, 715–722.
Weiss, M., Murray, C. & Weiss, G. (2002) Adults with attention-deficit/hyperactivity disorder: current concepts. Journal of Psychiatric Practice, 8, 99–111.
Wender, P. H. (1998) Attention-deficit hyperactivity disorder in adults. Psychiatric Clinics of North America, 21, 761–774.